// App-Quantinova.ai

TCT-8 : Impact of Aspirin Resistance on Outcomes after Coronary Events

Researchers

Presenter

  • Christine Chung

Principal Investigators

  • Ajay Kirtane

  • Claire Litherland

  • Bernhard Witzenbichler

  • Giora Weisz

  • Thomas Stuckey

  • Bruce Brodie

  • Michael Rinaldi

  • Franz-Josef Neumann

  • D. Christopher Metzger

Medical Centers

  • Cardiovascular Research Foundation, Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine, New York, New York, United States

  • Cone Health Heart and Vascular Center, Greensboro, North Carolina, United States

  • Columbia University, New York, New York, United States

  • Shaare Zedek Medical Center, Jerusalem, Israel

  • Newyork Presbyterian Hospital, Newyork, New York, United States

  • Universitaets-Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany

  • Sanger Heart and Vascular Institute/Carolinas Medical Center, Charlotte, North Carolina, United States

  • Cedars Sinai Medical Center, Los Angeles, California, United States

  • Cardiovascular Research Foundation, New York, United States

  • Lehigh Valley Health Network, Allentown, Pennsylvania, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

  • Helios Amper-Klinikum Dachau, Berlin, Germany

  • FirstHealth Cardiology Services, Pinehurst, North Carolina, United States

  • Wellmont CVA Heart Institute, Kingsport, United States

  • Cone Health Heart and Vascular Center, Greensboro, North Carolina, United States

Locations

  • United States

  • Germany

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Congestive heart failure

  • Renal insufficiency

  • Dyslipidemia

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved